FDA approves Bausch Lombs ophthalmic gel for postoperative inflammation and pain

FDA approves Bausch + Lomb’s ophthalmic gel for postoperative inflammation and pain

02:43 EST 26 Feb 2019 | Compelo Medical Devices

Lotemax SM takes the support of SubMicron (SM) technology to adhere to the ocular surface and then access crucial ocular tissues. The new gel delivers a submicron particle

The post FDA approves Bausch + Lomb’s ophthalmic gel for postoperative inflammation and pain appeared first on Compelo Medical Devices.

More From BioPortfolio on "FDA approves Bausch + Lomb’s ophthalmic gel for postoperative inflammation and pain"